Dr. Barry Dworkin

Ozempic and similar drugs linked to gastrointestinal conditions: B.C. researchers. Already known but needs context about rarity of some of the side effects versus the beneficial health outcomes when assessing overall risk of its use.

Medical Mythbusting Commentary for October 6, 2023

Source:
Ozempic and similar drugs linked to gastrointestinal conditions: B.C. researchers

Related posts:

  1. Study bias against methadone distribution clinics blinds them to the deficiencies of mental health cares services in Ontario
  2. Ottawa’s first safe-injection site approved by Health Canada
  3. Opioid death rate in the US has reduced average life expectancy
  4. Will the COVID antiviral medications be the Thor’s Hammer against SARS-CoV-2 and help mitigate the ravages of the pandemic? These are impressive drugs but there are logistical, social, geographical, and financial caveats to solve in the process.